www.fdanews.com/articles/185235-boston-scientific-gets-fda-nod-for-spinal-cord-stimulator-system
Boston Scientific Gets FDA Nod for Spinal Cord Stimulator System
January 17, 2018
The FDA approved Boston Scientific’s Spectra WaveWriter spinal cord stimulator system
“It is the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception therapy,” the company said.
The system is designed to customize the therapy it provides to the patient’s individual needs for pain relief as it allows for both therapy types to be combined and target a specific area, or they can used separately for managing multiple pain areas.